- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07758959
Comparison of Purse String Suture vs Transverse Mattress Suture to Maintain Hemostasis in Thinned-out Caesarean Sections Scars
Brief Summary The goal of this clinical trial is to compare the effectiveness of purse-string suture versus transverse mattress suture for achieving hemostasis in women with thinned-out lower uterine segment scars undergoing repeat cesarean section. The study aims to determine whether the purse-string suture technique provides faster and more effective hemostasis than the transverse mattress suture technique.
The main questions it aims to answer are:
- Does the purse-string suture reduce the time required to achieve hemostasis compared with the transverse mattress suture?
- Does the purse-string suture reduce the number of additional sutures required to achieve adequate hemostasis? Researchers will compare purse-string suturing with transverse mattress suturing to determine which technique achieves hemostasis more efficiently in women with thinned-out cesarean section scars.
Participants will:
- Undergo repeat cesarean section under standard surgical care.
- Be randomly assigned to receive either purse-string suturing or transverse mattress suturing for repair of the thinned-out lower uterine segment after closure of the first uterine layer.
- Have the time required to achieve hemostasis and the number of sutures required recorded intraoperatively.
- Receive routine postoperative management according to institutional protocols. Suggested improvement
Although the thesis mentions only time to achieve hemostasis and number of sutures as outcomes, ClinicalTrials.gov prefers that the primary outcome be clearly identified. Since your sample size was calculated using time to achieve hemostasis, I recommend presenting it as:
- Primary outcome: Time to achieve hemostasis (minutes)
- Secondary outcomes: Number of sutures required for hemostasis; duration of cesarean section (minutes)
Studieöversikt
Status
Intervention / Behandling
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54070
- Lahore General Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Females aged 18 to 40 years.
- Gestational age >37 weeks at the time of delivery.
- Parity <5.
- History of one or more previous cesarean sections.
- Intraoperative evidence of a thinned-out lower uterine segment scar during repeat cesarean section.
Exclusion Criteria:
- Preeclampsia (blood pressure ≥140/90 mmHg with proteinuria >+1 on dipstick).
- Gestational diabetes mellitus.
- Placental abnormalities, including placenta previa, placenta accreta spectrum (accreta/increta), or placental abruption.
- Previous uterine repair scar.
- Coagulation disorder (prothrombin time >15 seconds).
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Arm 1 Arm Title: Purse-String Suture
Participants undergoing repeat cesarean section with a thinned-out lower uterine segment scar underwent uterine repair using the purse-string suture technique to achieve hemostasis.
|
Purse-string suturing of the thinned-out lower uterine segment during repeat cesarean section.
|
|
Experimentell: Arm 2 Arm Title: Transverse Mattress Suture
Participants undergoing repeat cesarean section with a thinned-out lower uterine segment scar underwent uterine repair using the transverse mattress suture technique to achieve hemostasis.
|
Transverse mattress suturing of the thinned-out lower uterine segment during repeat cesarean section.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Time to Achieve Hemostasis
Tidsram: During the surgical procedure (intraoperative)
|
Time (in minutes) required to achieve complete hemostasis of the thinned-out lower uterine segment following application of the assigned suturing technique during repeat cesarean section.
|
During the surgical procedure (intraoperative)
|
|
Time to Achieve Hemostasis
Tidsram: Intraoperative (during cesarean section)
|
Time (in minutes) required to achieve complete hemostasis of the thinned-out lower uterine segment following application of the assigned suturing technique during repeat cesarean section.
|
Intraoperative (during cesarean section)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Number of Sutures Required to Achieve Hemostasis
Tidsram: Intraoperative (during cesarean section)
|
Number of hemostatic sutures required to achieve complete hemostasis of the thinned-out lower uterine segment during repeat cesarean section.
|
Intraoperative (during cesarean section)
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Andra studie-ID-nummer
- lahore general hospital
- irb no 199/24 (Annan identifierare: lahore general hospital)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
produkt tillverkad i och exporterad från U.S.A.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .